Hearing loss in Malawian children after bacterial meningitis: Incidence and risk factors

Audiological Medicine

Volumn 2, Issue 2, 2004, Pages 100-107

  Forsyth, Hope ^a   Kalumbi, Fanny ^c   Mphaka, Ethel ^c   Tembo, Madalitso ^b,c   Mwenechanya, James ^b,c   Kayira, Kondowani ^b,c   Bwanaisa, Loyd ^b,c   Njobvu, Alfred ^b,c   Walsh, Amanda ^c   Molyneux, Elisabeth ^b  

^a ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MALAWI   (Malawi)

^c MALAWI LIVERPOOL WELLCOME TRUST CLINICAL RESEARCH PROGRAMME   (Malawi)

Author keywords

Children; Hearing loss; Malawi; Meningitis; Risk factors

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; DEXAMETHASONE; GLUCOSE; PENICILLIN G; PROTEIN; STEROID;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID CULTURE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GRAM STAINING; HAEMOPHILUS INFLUENZAE; HEARING LOSS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALAWI; MALE; MORBIDITY; MORTALITY; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; SURVIVAL;

EID: 3242691383     PISSN: 1651386X     EISSN: None     Source Type: Journal    
DOI: 10.1080/16513860410033711     Document Type: Article

References (40)

1. Qazi SA, Khan MA, Mughal N, Ahmad M, Joomro Sakata Y, Kuriya N, et al. Dexamethasone and bacterial meningitis in Pakistan. Arch Dis Child 1996; 75: 482-8.
2. Carroll KJ, Carroll C. A prospective investigation of the long term auditory neurological sequelae associated with bacterial meningitis: a study from Vanuatu. Trop Med Hyg 1994; 97: 145-50.
3. Pomeroy SL, Holmes SJ, Dodge PR, Feigin RD. Seizures and other neurological sequelae of bacterial meningitis in children. N Eng J Med 1990; 323: 1651-7.
4. Fortnum H, Davis AC. Epidemiology of permanent childhood hearing impairment in the Trent Region 1985-1993. Br J Audiol 1997; 31: 409-46.
5. Hanna JN, Wild BE. Bacterial meningitis in children under five years of age in Western Australia. Med J Aust 1991; 155: 160-4.
6. Fortnum HM. Hearing impairment after bacterial meningitis: a review. Arch Dis Child 1992; 67: 1128-33.
7. Baraff L, Lee S, Schriger DL. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Inf Dis J 1993; 12: 389-94.
8. Dodge PR, Davis H, Feigin R, Holmes SJ, Kaplan SL, Jubelirer DP, et al. Prospective evaluation of hearing impairment as a sequel of acute bacterial meningitis. N Eng J Med 1984; 311: 869-73.
9. Fortnum HM, Davis A. Hearing impairment in children after bacterial meningitis: incidence and resource implications. Br J Audiol 1993; 27: 43-52.
10. Eisenhut M, Meehan T. Risk factors for hearing loss in bacterial meningitis: delay in treatment and clinical manifestations. J Audiol Med 2002; 11: 86-97.
11. Richardson MP, Reid A, Tarlow MJ, Rudd PT. Hearing loss during bacterial meningitis. Arch Dis Child 1997; 76: 134-8.
12. Nadol JB. Hearing loss as a sequela of meningitis. Laryngoscope 1978; 88: 739-55.
13. Bushan V, Chintu C. The changing pattern of pyogenic meningitis in Lusaka. East Afr Med J 1993; 56: 548-55.
14. Chotpitayasunondh T. Bacteriological meningitis in children, aetiology and clinical features, an 11-year review of 618 cases. SE Asian J Trop Med Publ Hlth 1994; 25: 107-15.
15. Zaki M, Daoud AS, El Saleh Q, West P. Childhood bacterial meningitis in Kuwait. J Trop Med & Hyg 1990; 93: 7-11.
16. Molyneux E, Walsh A, Phiri A, Molyneux M. Acute bacterial meningitis admitted to the Queen Elizabeth Central Hospital, Blantyre, Malawi in 1996-97. Trop Med & Int Hlth 2000; 3: 610-18.
17. Ciana G, Parmar N, Antonio C, Pivetta S, Tamburlini G, Cuttani M. Effectiveness of adjuvant treatment with steroids in reducing short term mortality in a high risk population of children with bacterial meningitis. J Trop Paeds 1995; 41: 164-7.
18. Molyneux EM, Walsh AL, Forsyth H, Tembo M, Mwenechanya J, Kayira K, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomized controlled trial. Lancet 2002; 360: 211-18.
19. Benjamin CM, Newton RW, Clarke MA. Risk factors for death from meningitis. Br Med J 1988; 296: 20.
20. Borkowski WJ, Goldgar DE, Gorga MP, Brookhouser PE, Worthington DW. Cerebrospinal fluid parameters and auditory brainstem responses following meningitis. Pediatr Neurol 1985; 1: 134-9.
21. Woolley AL, Kirk KA, Neumann AM, McWilliams SM, Murray J, Friend D, et al. Risk factors for hearing loss in meningitis in children. Arch Otolaryngol Head & Neck Surg 1999; 125: 509-14.
22. Gladstone MJ, Callaghan M, Rogerson SJ, Borgstein E, Rogerson SRK. HIV prevalence in paediatric admissions in Malawi. Arch Dis Child 2001; 84(Suppl 1): A43.
23. Rasmussen N, Johnsen NJ, Bohr VA. Otologic sequelae after pneumococcal meningitis: a survey of 164 consecutive cases with a follow-up of 94 survivors. Laryngoscope 1991; 101: 876-82.
24. Kotagel S, Rosenberg C, Rudd D, Dunkle LM, Horenstein S. Auditory evoked potentials in bacterial meningitis. Arch Neurol 1981; 38: 693-5.
25. McIntyre PB, Berkey CS, King SM, Schaad UB, Kilpi T, Kanra GY, et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 1997; 278: 925-31.
26. Richner B, Hof E, Prader A. Hearing impairment following therapy of Haemophilus influenzae meningitis. Helv Paediatr Acta 1979; 34: 443-7.
27. Radetsky M. Duration of symptoms and outcome in bacterial meningitis: an analysis of causation and the implication of a delay in diagnosis. Paediatr Infect Dis J 1992; 11: 694-8.
28. Kilpi T, Anttila M, Kallio MS, Peltolta H. Length of prediagnostic history related to the course and sequelae of childhood bacterial meningitis. Paediatr Infect Dis J 1993; 12: 184-8.
29. Vienney H, Displand PA, Luerscheg J, Deonna T, Dutoit-Marco ML, Gander C. Early diagnosis and evolution of deafness in childhood bacterial meningitis: a study using brain stem auditory evoked potentials. Pediatrics 1984; 73: 579-86.
30. Kaplan SL, Catlin FI, Weaver T, Feigin RD. Onset of hearing loss in children with bacterial meningitis. Pediatrics 1984; 73: 575-8.
31. Lebel MH, Freij BJ, Syrogiannopoulos GA, Chrane DR, Hoyt MJ, Stewart SM, et al. Dexamethasone therapy for bacterial meningitis: results of 2 double-blind placebo-controlled trials. N Engl J Med 1988; 319: 964-71.
32. Girgis NI, Sippel JE, Kilpatrick ME, Sanborn WR, Michail IA, Cross E, et al. Meningitis and encephalitis at the Abassa fever hospital, Cairo, Egypt from 1966-89. Am J Trop Med Hyg 1993; 48: 97-107.
33. Herson VC, Todd JK. Prediction of morbidity in Haemophilus influenzae meningitis. Pediatrics 1977; 59: 35-9.
34. Havens PL. Meta-analysis redux-steroids and meningitis revised (editorial). West J Med 1992; 157: 84-6.
35. Geiman BJ, Smith AL. Dexamethasone and bacterial meningitis: a meta-analysis of randomized controlled trials. West J Med 1992; 157: 27-31.
36. Quargliarello VJ, Scheld WM. Treatment of bacterial meninigitis. N Eng J Med 1997; 336: 708-14.
37. Prasad K, Haines T. Dexamethasone treatment for acute bacterial meninigitis: how strong is the evidence for routine use? J Neurol Neurosurg Psych 1995; 59: 31-7.
38. American Academy of Pediatrics. Dexamethasone therapy for bacterial meningitis in infants and children. In: Peter G, editor. 1994 Red Book: Report of the Committee on Infectious Diseases. 23rd ed. Elk grove Village, IL; American Academy of Pediatrics, 1994, pp. 558-9.
39. Macaluso A, Pivetta S, Maggi RS, Tamburlinin G, Catteano A. Dexamethasone adjunctive therapy for bacterial meningitis in children: a retrospective study in Brazil. Ann of Trop Paeds 1996; 16: 193-8.
40. Kanra G, Ozen H, Seemer G, Ceyhan M, et al. Beneficial effects of early dexamethasone in children with pneumococcal meningitis. Paediatr Inf Dis J 1995; 14: 490-4.